SCHEMBL296319

SCHEMBL296319

C=C1C(O)CC2CC1C2(C)C

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14484474 1.00 TSHR (0.36) TSHRMAPK1KDM4EHTTTDP1
SCHEMBL891743 1.00 TSHR (0.36) TSHRMAPK1KDM4EHTTTDP1
Rel-Menthone SCHEMBL3965684 0.76 EP300 (0.30)
SCHEMBL5186015 0.75 MEN1 (0.61)
3-Amino-Beta-Pinene SCHEMBL4272806 0.74 MAPK1 (0.41) TSHRMAPK1
SCHEMBL14497138 0.74 TSHR (0.36) TSHRMAPK1
SCHEMBL19621396 0.74 TSHR (0.36) TSHRMAPK1
SCHEMBL12812311 0.74 TSHR (0.36) TSHRMAPK1KDM4EHTTTDP1
SCHEMBL19621525 0.74 TSHR (0.36) TSHRMAPK1
SCHEMBL14463118 0.71 TSHR (0.32) TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4674922-A2 COMPOSITIONS COMPRISING 2,3,3,3-TETRAFLUOROPROPENE AND OXIDATION PRODUCTS The Chemours Company FC, LLC (US) 2026-01-07 EP claimed
EP-4623011-A1 A COMPOSITION AND FABRICATION OF SENSOR MATERIAL USING MOLECULAR IMPRINTED POLYMER LAYER FOR DETECTION OF VOLATILES Accubits Invent Private Limited (IN) 2025-10-01 EP claimed
US-20250113855-A1 HYDRATING AND REHYDRATING COMPOSITOIN AND PRODUCT IV THOUGHT PRODUCTS AND DESIGN CORP. 2025-04-10 US claimed
CN-119547794-A Composition for repelling and killing ticks as well as preparation method and application thereof 石河子大学 2025-03-04 CN claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
US-20240050337-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2024-02-15 US claimed
EP-4305122-A1 COMPOSITIONS COMPRISING 2,3,3,3-TETRAFLUOROPROPENE AND OXIDATION PRODUCTS The Chemours Company FC, LLC (US) 2024-01-17 EP claimed
US-20220364016-A1 PERFUME OIL MIXTURE SYMRISE AG (DE) 2022-11-17 US claimed
WO-2022187973-A1 DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH ALLIED CORP. (CA) 2022-09-15 WO claimed
CN-101522227-A Unit dose detergent dispenser with fragrance emitting assembly PROCTER & GAMBLE (US) 2009-09-02 CN claimed
US-20090047223-A1 Improvements in or Related to Organic Compoounds GIVAUDAN SA (CH) 2009-02-19 US claimed
WO-2008134212-A1 METHODS FOR TREATING FABRIC IN A DRYER THE DIAL COMPANY (US) 2008-11-06 WO claimed
EP-1966117-A1 IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS Givaudan SA (CH) 2008-09-10 EP claimed
WO-2007071085-A1 IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2007-06-28 WO claimed
CN-1237962-C Pharmaceutical use of Resina-Ferulae extract WANG YANDING (CN) 2006-01-25 CN claimed
CN-1579374-A Pharmaceutical use of Resina-Ferulae extract WANG YANDING (CN) 2005-02-16 CN claimed
CN-1548037-A Asafetida extract and its pharmaceutical use 王彦丁 2004-11-24 CN claimed
EP-1056739-B1 NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE PROCTER & GAMBLE (US) 2003-05-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047223-A1 Improvements in or Related to Organic Compoounds LPO, OTC, OAT TSHR 4355/4885MAPK1 4724/4885KDM4E 1830/4885
US-20240050337-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS OR10J3, OR51E2, MAL2 TSHR 4469/4885MAPK1 4300/4885KDM4E 1803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.